March 2021, the World Health Organization states that breast is now the most common site of cancer in women worldwide.
WHAT IS GOING ON AT FOCUSWEST HEALTH?
If you arrived here via www.focuswesthealth.com, you are in the correct place. The FocusWest Health Inc website is under construction.
Every breast imaging radiologist and facility will want this disruptive technology. There is no learning curve for the radiologist who will no longer need to repeat technologist’s scans.
The ROBOTIC WIDEFIELD BREAST ULTRASOUND TOMOGRAPHY PLATFORM (patented) (RoWBus™) eliminates many of the current breast ultrasound problems; * a severe shortage of trained ultrasound technologists, * precisely image the most breast tissue every examination, * correct comparison to images from other modalities and * minimize false positives. In partnership with AI DL RADIOMICS, it can safely find breast changes before the human eye. Without compression, manipulation, or distortion it is safe, repeatable and comfortable for women of all ages for diagnosis and screening.
FocusWest Health, a patient-oriented startup, has assembled a team of international experts, each of whom is a star in their respective areas of breast imaging, Radiomics, medical ultrasound and clinical care; another perspective that makes FocusWest Health unique.
A GLOBAL SOLUTION FOR THE EARLY DETECTION AND DIAGNOSIS OF BREAST CANCER WITH DIFFERENTIATION FROM THE NUMEROUS BENIGN CONDITIONS WHICH MIMIC CANCER IS NEEDED. WE BELIEVE FOCUSWEST HEALTH HAS THE SOLUTION.
Dr Philip Kivitz, a pioneer in the breast imaging/healthcare space and a board-certified radiologist, becomes the first “primary care physician for the breast” when he envisions, develops, establishes and leads the San Francisco Breast Evaluation Center (SFBEC). The current FocusWest Health patented technological innovation is based on a prior, FDA-approved breast ultrasound device that he and dozens of other breast imaging radiologists at the time used in their clinical practices.
Dr Kivitz decades of experience as Senior Reviewer and Inspector for MQSA inspecting mammography facilities across the US, talking with dozens of radiologists and training hundreds of technologists informs his knowledge of what the breast imaging radiologists want and need.
Contact: pghs456@gmail.com.
One Woman’s Story
A 38-year-old woman arrives at the San Francisco Breast Evaluation Center describing a gradually enlarging right breast mass. The innovative whole breast water-bath ultrasound device we were using at that time clearly reveals a benign cyst (fluid-filled)– a very common breast mass that is benign. In our practice we routinely image both breasts in search of any occult abnormalities - screening. This takes only a few more minutes.
An abnormal solid mass is found in the same breast but another area; the unsuspected mass is a pathology-proven invasive ductal carcinoma. It would have remained undetected until it grew large enough to feel and possibly spread to her lymph nodes. The mass was obscured on mammography by dense tissue. (the image below is from the more primitive ultrasound machine – 2.5 MhZ)
— October 1981
(Image: earlier ultrasound sensors created less detailed images than current sensors)
It is known that mammogram images with dense breast tissue can miss 20-40% of cancers. Dr Kivitz’ early pioneering medical ultrasound experience during his residency and research by others that supplemental ultrasound imaging could reveal early changes in mammographic dense tissue before it was generally appreciated. When appropriate, it became an integral part of the SFBEC patient experience along with the most innovative mammography, ultrasound guided fine needle biopsies, stereotactic x-ray fine needle biopsies and others.
Today, Dr Kivitz and the FocusWest Health team will bring their extensive experience in breast imaging and breast healthcare to women in need of Precision Medicine wherever there is a road.
Contact: pghs456@gmail.com.